Canada Life’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Canada Life’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-228	Closed	-$15K	–	2731
2018 Q1	$15K	Hold	228	–	–	﹤0.01%	2521
2017 Q4	$17K	Hold	228	–	–	﹤0.01%	2510
2017 Q3	$20K	Hold	228	–	–	﹤0.01%	2492
2017 Q2	$15K	Hold	228	–	–	﹤0.01%	2520
2017 Q1	$49K	Hold	228	–	–	﹤0.01%	2312
2016 Q4	$21K	Hold	228	–	–	﹤0.01%	2485
2016 Q3	$31K	Hold	228	–	–	﹤0.01%	2425
2016 Q2	$23K	Hold	228	–	–	﹤0.01%	2452
2016 Q1	$37K	Hold	228	–	–	﹤0.01%	2230
2015 Q4	$75K	Hold	228	–	–	﹤0.01%	1952
2015 Q3	$74K	Hold	228	–	–	﹤0.01%	1905
2015 Q2	$90K	Hold	228	–	–	﹤0.01%	1942
2015 Q1	$112K	Hold	228	–	–	﹤0.01%	1732
2014 Q4	$81K	Buy	+228	New	+$67.9K	﹤0.01%	1884

Other funds holding LUMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Canada Life's LUMO Position: Q2 2018 in Review

Canada Life sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2018, closing a stake of 228 shares — an estimated $15K sold.

Canada Life first reported a position in LUMO in Q4 2014 and held it in 14 quarters. The position peaked at $112K in Q1 2015. 106 funds tracked by Wall St. Rank hold LUMO as of Q2 2018.

Canada Life reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Canada Life sold 228 Lumos Pharma, Inc. Common Stock shares in Q2 2018, an estimated $15K.
Canada Life first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2014 and held it in 14 quarters.
Canada Life's Lumos Pharma, Inc. Common Stock position peaked at $112K in Q1 2015.
106 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2018.

Based on Canada Life's 13F filing for Q2 2018, filed 10 Aug 2018.